Literature DB >> 18641470

Integrating HIV care and HIV prevention: legal, policy and programmatic recommendations.

Robert H Remien1, Alan Berkman, Landon Myer, Francisco I Bastos, Ashraf Kagee, Wafaa M El-Sadr.   

Abstract

Since the start of the HIV epidemic we have witnessed significant advances in our understanding of the impact of HIV disease worldwide. Furthermore, breakthroughs in treatment and the rapid expansion of HIV care and treatment programmes in heavily impacted countries over the past 5 years are potentially critical assets in a comprehensive approach to controlling the continued spread of HIV globally. A strategic approach to controlling the epidemic requires continued and comparable expansion and integration of care, treatment and prevention programmes. As every new infection involves transmission, whether vertically or horizontally, from a person living with HIV/AIDS (PLWHA), the integration of HIV prevention into HIV care settings has the potential to prevent thousands of new infections, as well as to improve the lives of PLWHA. In this paper, we highlight how to better utilize opportunities created by the antiretroviral roll-out to achieve more effective prevention, particularly in sub-Saharan Africa. We offer specific recommendations for action in the domains of healthcare policy and practice in order better to utilize the advances in HIV treatment to advance HIV prevention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18641470      PMCID: PMC2788755          DOI: 10.1097/01.aids.0000327437.13291.86

Source DB:  PubMed          Journal:  AIDS        ISSN: 0269-9370            Impact factor:   4.177


  53 in total

1.  Efficacy of a preventive intervention for youths living with HIV.

Authors:  M J Rotheram-Borus; M B Lee; D A Murphy; D Futterman; N Duan; J M Birnbaum; M Lightfoot
Journal:  Am J Public Health       Date:  2001-03       Impact factor: 9.308

2.  Predicting the transmission of drug-resistant HIV: comparing theory with data.

Authors:  Sally M Blower; A Nick Aschenbach; Jim O Kahn
Journal:  Lancet Infect Dis       Date:  2003-01       Impact factor: 25.071

3.  The Serostatus Approach to Fighting the HIV Epidemic: prevention strategies for infected individuals.

Authors:  R S Janssen; D R Holtgrave; R O Valdiserri; M Shepherd; H D Gayle; K M De Cock
Journal:  Am J Public Health       Date:  2001-07       Impact factor: 9.308

4.  Effectiveness of an intervention to reduce HIV transmission risks in HIV-positive people.

Authors:  S C Kalichman; D Rompa; M Cage; K DiFonzo; D Simpson; J Austin; W Luke; J Buckles; F Kyomugisha; E Benotsch; S Pinkerton; J Graham
Journal:  Am J Prev Med       Date:  2001-08       Impact factor: 5.043

5.  Psychiatric disorders and drug use among human immunodeficiency virus-infected adults in the United States.

Authors:  E G Bing; M A Burnam; D Longshore; J A Fleishman; C D Sherbourne; A S London; B J Turner; F Eggan; R Beckman; B Vitiello; S C Morton; M Orlando; S A Bozzette; L Ortiz-Barron; M Shapiro
Journal:  Arch Gen Psychiatry       Date:  2001-08

6.  Watch, Discover, Think, and Act: evaluation of computer-assisted instruction to improve asthma self-management in inner-city children.

Authors:  L K Bartholomew; R S Gold; G S Parcel; D I Czyzewski; M M Sockrider; M Fernandez; R Shegog; P Swank
Journal:  Patient Educ Couns       Date:  2000-02

7.  Attitudes towards highly active antiretroviral therapy are associated with sexual risk taking among HIV-infected and uninfected homosexual men.

Authors:  David E Ostrow; Kelly J Fox; Joan S Chmiel; Anthony Silvestre; Barbara R Visscher; Peter A Vanable; Lisa P Jacobson; Steffanie A Strathdee
Journal:  AIDS       Date:  2002-03-29       Impact factor: 4.177

Review 8.  Alcohol use and HIV pharmacotherapy.

Authors:  Thomas F Kresina; Charles W Flexner; Jacqueline Sinclair; Maria Almira Correia; Jack T Stapleton; Samuel Adeniyi-Jones; Victoria Cargill; Laura W Cheever
Journal:  AIDS Res Hum Retroviruses       Date:  2002-07-20       Impact factor: 2.205

9.  Substance use and mental health correlates of nonadherence to antiretroviral medications in a sample of patients with human immunodeficiency virus infection.

Authors:  Joan S Tucker; M Audrey Burnam; Cathy D Sherbourne; Fuan-Yue Kung; Allen L Gifford
Journal:  Am J Med       Date:  2003-05       Impact factor: 4.965

10.  Association of depression with viral load, CD8 T lymphocytes, and natural killer cells in women with HIV infection.

Authors:  Dwight L Evans; Thomas R Ten Have; Steven D Douglas; David R Gettes; Mary Morrison; Margaret S Chiappini; Priscilla Brinker-Spence; Carla Job; Delinda E Mercer; Yan Lin Wang; Dean Cruess; Benoit Dube; Erik A Dalen; Tiffany Brown; Russell Bauer; John M Petitto
Journal:  Am J Psychiatry       Date:  2002-10       Impact factor: 18.112

View more
  6 in total

1.  Structural barriers to ART adherence in Southern Africa: Challenges and potential ways forward.

Authors:  A Kagee; R H Remien; A Berkman; S Hoffman; L Campos; L Swartz
Journal:  Glob Public Health       Date:  2011

2.  Retention in HIV care for individuals not yet eligible for antiretroviral therapy: rural KwaZulu-Natal, South Africa.

Authors:  Richard J Lessells; Portia C Mutevedzi; Graham S Cooke; Marie-Louise Newell
Journal:  J Acquir Immune Defic Syndr       Date:  2011-03-01       Impact factor: 3.731

Review 3.  Secondary prevention of HIV in the United States: past, current, and future perspectives.

Authors:  Jeffrey D Fisher; Laramie R Smith; Erin M Lenz
Journal:  J Acquir Immune Defic Syndr       Date:  2010-12       Impact factor: 3.731

Review 4.  Secondary prevention of HIV infection: the current state of prevention for positives.

Authors:  Jeffrey D Fisher; Laramie Smith
Journal:  Curr Opin HIV AIDS       Date:  2009-07       Impact factor: 4.283

5.  Prevention counseling for HIV-infected persons: what every clinician needs to know.

Authors:  Wayne A Duffus; Ikechukwu U Ogbuanu
Journal:  Curr Infect Dis Rep       Date:  2009-07       Impact factor: 3.725

6.  Characteristics and outcomes among older HIV-positive adults enrolled in HIV programs in four sub-Saharan African countries.

Authors:  Eduard Eduardo; Matthew R Lamb; Sasi Kandula; Andrea Howard; Veronicah Mugisha; Davies Kimanga; Bonita Kilama; Wafaa El-Sadr; Batya Elul
Journal:  PLoS One       Date:  2014-07-30       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.